The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »
Dive Brief: Congressional support for permanently expanding access to telehealth seems to be rising, though thorny questions persist around payment, timing and which flexibilities should be retained after the COVID-19 public health emergency expires. In a House subcommittee panel on telehealth Tuesday, lawmakers on both side of the aisle were supportive of the modality, especially… Read More »
In the period from October 2015 to September 2016, before the Affordable Care Act, a substantial portion of Medicare patients referred to home healthcare after hospitalization did not receive that care, new findings show. Using national data, the researchers detailed how often Medicare patients referred to home healthcare services after a hospital discharge received one… Read More »
Dive Brief: The Medicare program overpaid providers more than $ 267 million due to inadequate oversight of patients discharged from an acute care hospital within three days of their admission, according to a new report by the HHS Office of the Inspector General. OIG inspectors combed over more than 89,000 claims filed in fiscal 2016… Read More »